Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcomes of second-line treatment after fludarabine cyclophosphamide and rituximab in patients with chronic lymphocytic leukemia outside clinical trials.
Joffe E, Goldschmidt N, Bairey O, Fineman R, Ruchlemer R, Rahimi-Levene N, Shvidel L, Greenbaum U, Aviv A, Tadmor T, Braester A, Arad A, Polliack A, Herishanu Y; Israeli CLL Study Group. Joffe E, et al. Among authors: tadmor t. Eur J Haematol. 2018 Sep;101(3):399-406. doi: 10.1111/ejh.13129. Epub 2018 Aug 3. Eur J Haematol. 2018. PMID: 29949186
Sorafenib - a small molecule with big promise?
Tadmor T, Tallman MS, Polliack A. Tadmor T, et al. Leuk Lymphoma. 2010 Feb;51(2):181-2. doi: 10.3109/10428190903470893. Leuk Lymphoma. 2010. PMID: 20001865 No abstract available.
Associations between multiple myeloma and other malignancies.
Landgren O, Polliack A, Tadmor T. Landgren O, et al. Among authors: tadmor t. Leuk Lymphoma. 2011 Feb;52(2):161-2. doi: 10.3109/10428194.2010.538942. Epub 2011 Jan 24. Leuk Lymphoma. 2011. PMID: 21261502 No abstract available.
191 results